Recursos de colección

UCL University College London Eprints (372.813 recursos)

UCL Eprints collects the work of UCL researchers and makes it freely available over the web, helping the worldwide scholarly community to discover UCL research. Institutional repositories like UCL Eprints complement the traditional academic publishing and scholarly communications processes. They raise the visibility of research and help to maximise its impact. UCL researchers are encouraged to deposit a copy of each journal article, conference paper, working paper, and any other research output, in the UCL Eprints at the earliest opportunity, ensuring that their research reaches as wide an audience as possible.

Mostrando recursos 1 - 20 de 376.637

  1. ROLE OF MRTF-A PATHWAY IN SCLERODERMA-RELATED FIBROSIS

    Singh, A; Shiwen, X; Nikitorowicz-Buniak, J; Abdi, BA; Ponticos, M; Denton, C; Abraham, D; Smith, B; Stratton, R

  2. Computational Diffusion MRI and Brain Connectivity, MICCAI Workshops CDMRI/MMBC, Nagoya, Japan, September 22nd, 2013


  3. Advances in DIY Health and Wellbeing.

    O'Kane, AA; Hurst, A; Niezen, G; Marquardt, N; Bird, J; Abowd, GD

  4. TYPE2 ANTI-CD20 ANTIBODIES DO NOT RAPIDLY INTERNALISE FROM THE SURFACE OF B CELLS FROM PATIENTS WITH RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS AND LYSE THEM MORE EFFICIENTLY THAN RITUXIMAB (TYPE 1 ANTI-20ANTIBODY)

    Reddy, V; Cambridge, G; Isenberg, D; Cragg, M; Leandro, M

  5. CHANGES IN THE RELATIONSHIP BETWEEN BAFF, BAFF-R AND B CELL PHENOTYPE FOLLOWING TREATMENT WITH RITUXIMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

    Reddy, V; Garcia, GM; Isenberg, D; Leandro, M; Cambridge, G

  6. EFFECT OF RITUXIMAB ON DIFFERENT ISOTYPES OF SERUM IMMUNOGLOBULINS IN PATIENTS WITH SLE

    Reddy, V; Martinez, L; Isenberg, D; Cambridge, G; Leandro, M

  7. FALLING STANDARDS AND BREAKING BAD HABITS: AN EVALUATION OF CLINICAL PRACTICE

    Farah, Z; Sbai, M; Reddy, V

  8. GENETIC RISK FACTORS IN IDIOPATHIC INFLAMMATORY MYOPATHIES ARE SHARED WITH OTHER AUTOIMMUNE DISORDERS IN EUROPEAN POPULATIONS

    Jani, M; Massey, J; Wedderburn, L; Vencovsky, J; Danko, K; Lundberg, I; Selva-O'Callaghan, A; Radstake, T; Platt, H; Warren, R; Griffiths, C; Padyukov, L; Lee, A; Gregersen, P; Ollier, W; Cooper, R; Chinoy, H; Lamb, J; EUMYONET,

  9. SERUM LEVELS OF CXCL13 ARE INCREASED IN UNTREATED PATIENTS WITH RHEUMATOID ARTHRITIS FROM THE FIRST WEEKS OF DISEASE DEVELOPMENT

    Moura, RA; Canhaeo, H; Polido-Pereira, J; Navalho, M; Leandro, MJ; Cambridge, G; Fonseca, JE

  10. INTERIM SAFETY AND EFFICACY RESULTS OF PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME PARTICIPATING IN THE beta-CONFIDENT REGISTRY

    Kuemmerle-Deschner, JB; Tilson, HH; Hawkins, PN; van der Poll, T; Walker, UA; Abrams, K; Hoffman, HM

  11. RAYNAUD'S PHENOMENON AND SYSTEMIC SCLEROSIS

    Denton, CP

  12. Just a graze? Cephalic tetanus presenting as a stroke mimic

    Doshi, A; Warrell, C; Dahdaleh, D; Kullmann, D

  13. Nicotine exposure reduces N-methyl-D-aspartate toxicity in the hippocampus: relation to distribution of the alpha7 nicotinic acetylcholine receptor subunit.

    Prendergast, MA; Harris, BR; Mayer, S; Holley, RC; Pauly, JR; Littleton, JM
    BACKGROUND: Exposure to nicotine has been shown to promote neuronal survival after excitotoxic insult to the brain. The role of specific nicotinic acetylcholine receptors (nAChRs) subtypes in mediating this effect is not well understood, however. Examination of distinct receptor subtypes in promoting neuronal survival is of importance not only in understanding the regulation of necrotic cell death but potentially in the development of novel pharmacological therapies that may reduce this form of neurodegeneration. MATERIAL AND METHODS: The present studies examined the relationship between distribution of alpha7 subunit-bearing nAChRs, using autoradiographic imaging of [125I]alpha-bungarotoxin binding, and protective effects of nicotine against...

  14. Comparison of short-wavelength reduced-illuminance and conventional autofluorescence imaging in Stargardt Macular Dystrophy.

    Strauss, RW; Muñoz, B; Jha, A; Ho, A; Cideciyan, AV; Kasilian, ML; Wolfson, Y; Sadda, S; West, S; Scholl, HP; Michaelides, M
    PURPOSE: To compare grading results between short-wavelength reduced-illuminance versus conventional autofluorescence imaging in Stargardt Macular Dystrophy. DESIGN: Reliability study. METHODS: Setting: Moorfields Eye Hospital, London (United Kingdom) Patients: 18 patients (18 eyes) with Stargardt Macular Dystrophy. OBSERVATION PROCEDURES: a series of three fundus autofluorescence images using three different acquisition parameters on a custom-patched device were obtained: (i) 25% laser power and total sensitivity 87; (ii) 25% laser power and freely adjusted sensitivity; and (iii) 100% laser power and freely adjusted total sensitivity (conventional). The total area of two hypo-autofluorescent lesion types (definitely decreased autofluorescence and poorly-demarcated questionably decreased autofluorescence) was...

  15. Cone opsins, colour blindness and cone dystrophy: Genotype-phenotype correlations

    Gardner, JC; Michaelides, M; Hardcastle, AJ
    © 2016, South African Medical Association. All Rights Reserved.X-linked cone photoreceptor disorders caused by mutations in the OPN1LW (L) and OPN1MW (M) cone opsin genes on chromosome Xq28 include a range of conditions from mild stable red-green colour vision deficiencies to severe cone dystrophies causing progressive loss of vision and blindness. Advances in molecular genotyping and functional analyses of causative variants, combined with deep retinal phenotyping, are unravelling genetic mechanisms underlying the variability of cone opsin disorders.

  16. Unilateral BEST1-associated Retinopathy.

    Arora, R; Khan, K; Kasilian, M; Strauss, RW; Holder, GE; Robson, AG; Thompson, DA; Moore, AT; Michaelides, M
    PURPOSE: To describe a series of patients with molecularly confirmed mutation in BEST1 causing Best Disease but with unilateral clinical manifestation. DESIGN: Retrospective observational case series. METHODS: Setting: Moorfields Eye Hospital and Great Ormond Street Hospital, London (United Kingdom). PATIENTS: Five patients (ten eyes) with uniocular manifestation of BEST1 mutation causing Best Disease were ascertained retrospectively from the clinical and genetic databases. MAIN OUTCOME MEASURES: Patients had full ophthalmological examination, color fundus photography, fundus autofluorescence imaging, spectral-domain optical coherence tomography, and detailed electrophysiological assessment. Genetic testing was performed. RESULTS: All cases had a clinical appearance typical and consistent with Best...

  17. 004 Simultaneous invasive pressure and flow measurements during atrioventricular delay improvement reveal a compensatory peripheral vasodilator response which attenuates the initial blood pressure increment: implications for the design of optimisation protocols: Abstract 004 Figure 1

    Pabari, PA; Kyriacou, A; Wright, I; Hughes, AD; Mayet, J; Whinnett, ZI; Francis, DP; Manisty, CH

  18. 003 Validating markers of mechanical dyssynchrony by experimental manipulation of interventricular timings: what is needed to make them a reasonable prospect for cardiac resynchronisation therapy selection?

    Pabari, PA; Moraldo, M; Hughes, AD; Mayet, J; Kyriacou, A; Francis, DP; Manisty, CH

  19. 019 Development and validation of a novel pressure-only intra-coronary index of coronary stenosis severity

    Sen, S; Escaned, J; Malik, I; Mikhail, G; Foale, R; Mila, R; Tarkin, J; Petraco, R; Broyd, C; Jabbour, R; Sethi, A; Baker, C; Bellamy, M; Al-Bustami, M; Hackett, D; Khan, M; Lefroy, D; Parker, K; Hughes, A; Francis, D; Di Mario, C; Mayet, J; Davies, J

  20. RESTRICTIVE VERSUS LIBERAL BLOOD TRANSFUSION FOR ACUTE UPPER GASTROINTESTINAL BLEEDING: CLUSTER RANDOMISED FEASIBILITY TRIAL

    Jairath, V; Kahan, B; Gray, A; Dore, C; Palmer, K; Travis, S; Logan, R; Walsh, T; Murphy, M; Investigators, TRIGGER

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.